Literature DB >> 3829301

Plasma concentrations of fentanyl in infants, children and adults.

M A Singleton, J I Rosen, D M Fisher.   

Abstract

To evaluate whether there are age-related differences in the plasma concentration-vs-time course of fentanyl, the authors administered fentanyl to seven infants (3-10 months), seven children (1-9 years) and seven adults (18-41 years). Anaesthesia was induced with thiopentone, nitrous oxide, and pancuronium; following tracheal intubation, fentanyl (approximately 30 micrograms X kg-1 for infants and children, 20 micrograms X kg-1 for adults) was administered as a 2-min IV infusion. Anaesthesia was maintained with nitrous oxide, pancuronium, and morphine sulphate as clinically indicated. Plasma samples were obtained for 4 h and fentanyl concentrations determined by radioimmunoassay. Plasma concentrations per microgram X kg-1 fentanyl administered were lowest in infants 4-10 and 60-240 min after the start of the 2-min infusion; values for children were lower than those for adults 4, 180 and 210 min after the start of the 2-min infusion. These findings are consistent with the authors' clinical observation that infants tolerate larger doses of fentanyl than do adults.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829301     DOI: 10.1007/BF03015333

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  12 in total

1.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

2.  Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth.

Authors:  B Friis-Hansen
Journal:  Pediatrics       Date:  1971-01       Impact factor: 7.124

3.  Antibodies to fentanyl.

Authors:  G L Henderson; J Frincke; C Y Leung; M Torten; E Benjamini
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

4.  Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays.

Authors:  D Rodbard
Journal:  Anal Biochem       Date:  1978-10-01       Impact factor: 3.365

5.  Comparative pharmacokinetics of fentanyl and alfentanil.

Authors:  S Bower; C J Hull
Journal:  Br J Anaesth       Date:  1982-08       Impact factor: 9.166

6.  Optimization of the radioimmunoassays for measuring fentanyl and alfentanil in human serum.

Authors:  J Schüttler; P F White
Journal:  Anesthesiology       Date:  1984-09       Impact factor: 7.892

7.  Ventilatory depression related to plasma fentanyl concentrations during and after anesthesia in humans.

Authors:  P Cartwright; C Prys-Roberts; K Gill; A Dye; M Stafford; A Gray
Journal:  Anesth Analg       Date:  1983-11       Impact factor: 5.108

8.  Liver circulation and function during isoflurane and halothane anesthesia.

Authors:  S Gelman; K C Fowler; L R Smith
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

9.  Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography--mass spectrometry.

Authors:  T Goromaru; H Matsuura; N Yoshimura; T Miyawaki; T Sameshima; J Miyao; T Furuta; S Baba
Journal:  Anesthesiology       Date:  1984-07       Impact factor: 7.892

10.  Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery.

Authors:  R J Hudson; I R Thomson; J E Cannon; R M Friesen; R C Meatherall
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

View more
  13 in total

1.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

2.  Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

3.  Concentration of fentanyl in colostrum after an analgesic dose.

Authors:  P L Steer; C J Biddle; W S Marley; R K Lantz; P L Sulik
Journal:  Can J Anaesth       Date:  1992-03       Impact factor: 5.063

4.  Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children.

Authors:  Fanuel T Hagos; Christopher M Horvat; Alicia K Au; Yvette P Conley; Lingjue Li; Samuel M Poloyac; Patrick M Kochanek; Robert S B Clark; Philip E Empey
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

Review 5.  Pain management in the critically ill child.

Authors:  M Yaster; D G Nichols
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 1.967

6.  Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.

Authors:  Sara L Van Driest; Matthew D Marshall; Brian Hachey; Cole Beck; Kim Crum; Jill Owen; Andrew H Smith; Prince J Kannankeril; Alison Woodworth; Richard M Caprioli; Leena Choi
Journal:  Br J Clin Pharmacol       Date:  2016-04-15       Impact factor: 4.335

Review 7.  Current guidelines for the treatment of acute pain in children.

Authors:  V Bhatt-Mehta
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 8.  Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

9.  [Analgesia with opioids in the paediatric patient.].

Authors:  C Schlünder
Journal:  Schmerz       Date:  1992-12       Impact factor: 1.107

10.  [Specific aspects of perioperative pain relief in children.].

Authors:  B U Wangemann
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.